Whether to strive for the go ahead touchdown to score or else defend the slimmest of leads? It’s an intense decision at a critical time in the game. Similarly, in the Pediatric Intensive Care Units at two rival schools – The Ohio State University and The University of Michigan - critical decisions are made every day. Only this is not a game. In the Pediatric Intensive Care Units (ICU) of C.S. Mott Children’s Hospital in Ann Arbor, Michigan and Nationwide Children’s Hospital in Columbus, Ohio care providers are there at critical times for our most vulnerable children – children battling cancer, heart disease, head trauma, pneumonia, diabetes, and many other illnesses.
Despite being rivals on the football field, researchers at OSU/Nationwide Children’s and U-M/C.S. Mott Children’s Hospital have been strong partners in our charge to better understand children who are critically ill so we can snatch them back from the cliff’s edge to give us a chance to cure them of their diseases. Help us help them by supporting innovative critical care research initiatives aimed at discovering new treatments, providing the highest quality care, and teaching the next generation of critical care providers.
Between now and the end of the Michigan/Ohio State football game on 11/26, both Pediatric ICUs will be raising funds in a friendly competition to support our critical work.
Donations will stay and be used at their designated sites regardless of the outcome on the gridiron! Donations to the OSU/Nationwide Children’s team will support clinical and translational research programs dedicated to learning from our sickest patients and developing new treatments to save and improve the lives of critically ill children. Donations to the U-M team will forever help by growing The LIFE Fund, an endowment established in 2015 for the sole purpose of ensuring the optimal care of critically ill and injured children for generations to come. The LIFE Fund will specifically support innovative research projects, fellow advanced educational programs, national and international outreach efforts, quality improvement and patient safety initiatives, and novel new therapies. So, please, if you are fortunate to help, help us help them.